PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19167408-10	2009	On the contrary, cells treated with phorbol-12-myristate-13-acetate (PMA) had an increase in type II VLDLR expression, whereas the beta-catenin was increased.	Tetradecanoylphorbol Acetate	36-67	very low density lipoprotein receptor	Homo sapiens	101-106	
19167408-10	2009	On the contrary, cells treated with phorbol-12-myristate-13-acetate (PMA) had an increase in type II VLDLR expression, whereas the beta-catenin was increased.	Tetradecanoylphorbol Acetate	69-72	very low density lipoprotein receptor	Homo sapiens	101-106	
11010963-3	2001	Here, we report that the ligand binding activity of the VLDL-R in THP-1 monocytic cells, endothelial cells, smooth muscle cells, and VLDL-R-transfected HEK 293 cells is diminished after treatment with phorbol 12-myristate 13-acetate.	Tetradecanoylphorbol Acetate	201-232	very low density lipoprotein receptor	Homo sapiens	56-62	
11010963-3	2001	Here, we report that the ligand binding activity of the VLDL-R in THP-1 monocytic cells, endothelial cells, smooth muscle cells, and VLDL-R-transfected HEK 293 cells is diminished after treatment with phorbol 12-myristate 13-acetate.	Tetradecanoylphorbol Acetate	201-232	very low density lipoprotein receptor	Homo sapiens	133-139	
11222479-3	2001	This study investigates the effect of interferon (IFN)-gamma on VLDL receptor expression in phorbol-12-myristate-13-acetate (PMA)-treated THP-1, HL-60 macrophages, and human monocyte-derived macrophages.	Tetradecanoylphorbol Acetate	92-123	very low density lipoprotein receptor	Homo sapiens	64-77	
11222479-3	2001	This study investigates the effect of interferon (IFN)-gamma on VLDL receptor expression in phorbol-12-myristate-13-acetate (PMA)-treated THP-1, HL-60 macrophages, and human monocyte-derived macrophages.	Tetradecanoylphorbol Acetate	125-128	very low density lipoprotein receptor	Homo sapiens	64-77	
11222479-7	2001	In THP-1 macrophages, VLDL receptor protein expression decreased at 2 days after PMA treatment but increased at 3 days and increased up to 5 days.	Tetradecanoylphorbol Acetate	81-84	very low density lipoprotein receptor	Homo sapiens	22-35